Eugenia Kraynov - Pfizer | 人才画像

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 51 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pharmacokinetics, Pharmacodynamics, and Toxicity of a PD-1-targeted IL-15 in Cynomolgus Monkeys

Changhua Ji,Bing Kuang,Bernard S. Buetow,Allison Vitsky,Yuanming Xu, Tzu-Hsuan Huang,Javier Chaparro-Riggers,Eugenia Kraynov, Diane Matsumoto

PLOS ONEno. 2 (2024)

引用0浏览0WOS引用

Supplemetal Figures 1 and 2 from RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, is Highly Efficacious in Preclinical Solid Tumor Models

Pavel Strop,Thomas-Toan Tran,Magdalena Dorywalska,Kathy Delaria,Russell Dushin,Oi Kwan Wong,Wei-Hsien Ho,Dahui Zhou,Aidong Wu,Eugenia Kraynov,Laura Aschenbrenner,Bora Han, Christopher J. O'Donnell,Jaume Pons,Arvind Rajpal,Dave L. Shelton,Shu-Hui Liu

crossref（2023）

引用0浏览0引用

Breaching the DNA Damage Checkpoint Via PF-00477736, a Novel Small-Molecule Inhibitor of Checkpoint Kinase 1

Alessandra Blasina, Jill Hallin,Enhong Chen, Maria Elena Arango,Eugenia Kraynov, James Register, Stephan Grant, Sacha Ninkovic, Ping Chen, Tim Nichols, Patrick O'Connor,Kenna Anderes

openalex（2023）

引用218浏览0WOS引用

218

Figure S8 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

Amir A. Al-Khami,Sawsan Youssef,Yasmina Abdiche,HoangKim Nguyen,Jeffrey Chou,Christopher R. Kimberlin,Sherman M. Chin,Cris Kamperschroer,Bart Jessen,Brent Kern,Natalija Budimir,Christopher P. Dillon,Allison Xu, Jerry D. Clark,Eugenia Kraynov,Arvind Rajpal, John C. Lin, Shahram Salek-Ardakani

openalex（2023）

引用0浏览0引用

Figure S1 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

openalex

引用0浏览0引用

Figure S16 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

openalex（2023）

引用0浏览0引用

Figure S13 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

openalex（2023）

引用0浏览0引用

Figure S10 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

Amir A. Al-Khami,Sawsan Youssef,Yasmina Abdiche,HoangKim Nguyen,Joyce Chou,Christopher R. Kimberlin,Sherman M. Chin,Cris Kamperschroer,Bart Jessen,Brent Kern,Natalija Budimir,Christopher P. Dillon,Allison Xu, Jerry D. Clark,Jeffrey Chou,Eugenia Kraynov,Arvind Rajpal, John C. Lin, Shahram Salek-Ardakani

openalex（2023）

引用0浏览0引用

Figure S13 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn